Seuraa
Seyed Moayed Alavian
Seyed Moayed Alavian
Professor of Internal Medicine-Research Center,Middle East Liver Disease Center, tehran, Iran
Vahvistettu sähköpostiosoite verkkotunnuksessa thc.ir - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic …
SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1789-1858, 2018
104942018
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and …
JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ...
The lancet 392 (10159), 1923-1994, 2018
6596*2018
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the …
T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ...
The Lancet 390 (10100), 1211-1259, 2017
63272017
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 …
HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1859-1922, 2018
38122018
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
21992017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
16562018
The changing epidemiology of viral hepatitis B in Iran
SM Alavian, F Fallahian, KB Lankarani
Journal of Gastrointestinal and Liver Diseases 16 (4), 403-406, 2007
3412007
Health literacy and the influencing factors: a study in five provinces of Iran
SA Tehrani Banihashemi, AA Haghdoost, MA Amirkhani, SM Alavian, ...
Strides in development of medical education 4 (1), 1-9, 2007
3072007
Effect of aerobic and resistance exercise training on liver enzymes and hepatic fat in Iranian men with nonalcoholic fatty liver disease
A Shamsoddini, V Sobhani, MEG Chehreh, SM Alavian, A Zaree
Hepatitis monthly 15 (10), e31434, 2015
2932015
Hepatitis B Virus infection in Iran: A systematic review
SM Alavian, B Hajarizadeh, M AHMADZADASL, A Kabir, LK BAGHERI
Hepatitis Monthly 8 (421), 281-294, 2008
2692008
Hepatitis D Virus Infection; Iran, Middle East and Central Asia
S Alavian
Hepatitis Monthly 5 (4), 137-143, 2005
269*2005
Hepatitis C virus in Iran: Epidemiology of an emerging infection
SM Alavian, P Adibi, MR ZALI
ARCHIVES OF IRANIAN MEDICINE 8 (2), 84-90, 2005
2422005
Hepatitis C risk factors in Iranian volunteer blood donors: A case–control study
SM Alavian, B Gholami, S Masarrat
Journal of Gastroenterology and Hepatology 17 (10), 1092-1097, 2002
2342002
The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach
HF Huseini, SM Alavian, R Heshmat, MR Heydari, K Abolmaali
Phytomedicine 12 (9), 619-624, 2005
2302005
Health in the Islamic Republic of Iran, challenges and progresses
KB Lankarani, SM Alavian, P Peymani
Medical journal of the Islamic Republic of Iran 27 (1), 42, 2013
2112013
Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study
S Mirmomen, SM Alavian, B Hajarizadeh, J Kafaee, B Yektaparast, ...
Archives of Iranian medicine 9 (4), 319-323, 2006
1992006
Hepatoprotective effect of quercetin: From chemistry to medicine
S Miltonprabu, M Tomczyk, K Skalicka-Woźniak, L Rastrelli, M Daglia, ...
Food and Chemical Toxicology 108, 365-374, 2017
1932017
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind …
SA Jazayeri-Tehrani, SM Rezayat, S Mansouri, M Qorbani, SM Alavian, ...
Nutrition & metabolism 16, 1-13, 2019
1912019
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ...
The lancet Gastroenterology & hepatology 8 (10), 879-907, 2023
1892023
Apoptosis in liver diseases-detection and therapeutic applications
S Ghavami, M Hashemi, K Kadkhoda, SM Alavian, GH Bay, MJ Los
Medical science monitor 11 (11), RA337-RA345, 2005
1862005
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20